Single-Cell Cancer (2021)

15 April 2022
20 April 2022

Single-Cell Cancer is one of the CTM themed issues with a special focus on the understanding of transcriptomic atlas of cancer cells and immune cells, intercellular communication within the microenvironment, and cell heterogeneity for malignancy and metastasis. This Issue provides new insights for clinicians in defining molecular mechanisms of cancer development and precise decision making with regards to individual therapies. This Issue presents various strategies and designs of clinical cancer research at single-cell solution, empowers the new concept of spatiotemporal molecular medicine, and offers opportunities to develop new diagnosis and therapy for cancer.

Edited by: Professor Xiangdong Wang, Editor-in-Chief of Clinical and Translational Medicine

Table of Contents

Open Access

Multiregion single-cell sequencing reveals the transcriptional landscape of the immune microenvironment of colorectal cancer

Multiregion single-cell sequencing reveals the transcriptional landscape of the immune microenvironment of colorectal cancer

Integrated single-cell RNA sequencing technologies reveal a high-resolution immune landscape of colorectal primary tumors and liver metastasis, identifying major immune cell types and distinct cell functional states of T and B cells as well as predictions of complex cell-cell interactions.

Open Access

Single-cell analyses reveal suppressive tumor microenvironment of human colorectal cancer

Single-cell analyses reveal suppressive tumor microenvironment of human colorectal cancer

1) Single-cell profiling of clinical samples of 12 human colorectal cancer patients.

2) Tumor mutational burden states of human CRC contribute to distinct immune profile patterns.

3) Single-cell analysis in human CRC identified phenotypic and functional diversity of tumor-associated macrophages and T cells.

Open Access

Diversity and intratumoral heterogeneity in human gallbladder cancer progression revealed by single-cell RNA sequencing

Diversity and intratumoral heterogeneity in human gallbladder cancer progression revealed by single-cell RNA sequencing

  • Abundant immune cells in adenocarcinoma and squamous cell carcinoma while stromal cells in neuroendocrine neoplasms were enriched.

  • Immunosuppressive microenvironment characterized as exhausted T cells and APOE+ macrophages.

  • Endothelial cells (KDR+ and ACKR1+) indicated that angiogenesis and lymphangiogenesis were involved in GC.

  • There were remarkable ligand–receptor interactions between endothelial, primary GC cells, and macrophages.

Open Access

Landscape and dynamics of single tumor and immune cells in early and advanced-stage lung adenocarcinoma

Landscape and dynamics of single tumor and immune cells in early and advanced-stage lung adenocarcinoma

  1. Our study comprehensively studied the tumor microenvironment (TME)and intra-tumor heterogeneity (ITH) in different stages of LUAD by both scRNA-seq and bulk RNA-seq analyses.
  2. Based on these high-quality cells derived from different tissues, our results revealed the cellular diversity and molecular complexity of cell lineages in different stages of LUAD.
  3. This study, which serves as a basic framework and valuable resource, can facilitate exploration of the pathogenesis of LUAD and identify novel therapeutic targets in the future.

Open Access

A cellular census of human peripheral immune cells identifies novel cell states in lung diseases

A cellular census of human peripheral immune cells identifies novel cell states in lung diseases

1. New clusters and functions of circulating immune cells can be an important source to understand molecular mechanisms, identify disease-specific biomarkers, and develop new target therapies.

2. The difference of biological processes and pathways of PBICs by single-cell sequencing and RNAseq varies among diseases.

3. The interstitial cells could alter the differentiation and development of the immune cell types and immune function.